At least 97,000 US children tested positive for coronavirus disease 2019 (COVID-19) in the last 2 weeks of July; AbbVie will pay $24 million for illegally tempting doctors and nurses to prescribe Humira; airlines are considering banning those who refuse to wear masks.
A small study out of Sweden adds to context to the puzzle of how best to treat patients with multiple myeloma who contract COVID-19.
Andria Jacobs, RN, MS, CEN, CPHQ, chief operating officer for PCG Software, discusses 3 billing and claims issues facing the health care industry in the wake of the COVID-19 pandemic.
A new study in PLOS ONE has highlighted the broad impact fatigue can have on patients with rheumatoid arthritis (RA), psoriatic arthritis, and axial spondyloarthritis.
Beyond telework, some notable strategies that employers should consider when managing back-to-school and other leave related concerns among employees include child care benefits and flexible work options, said David Weisenfeld, JD, legal editor and host of a XpertHR podcast.
A rule change to let those with end-stage renal disease enroll in Medicare Advantage has a twist that could stop patients from learning if their dialysis center iis in the network.
A risk prediction model based on high-resolution computed tomography (HRCT) variables outperformed other models when predicting mortality among patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
A new study has found that muscle loss can lead to increased rates of mortality and morbidity in patients with chronic obstructive pulmonary disease (COPD). However, one expert remains skeptical whether the study represents the full scope of patients at risk.
Delays in surgery to treat early-stage breast cancer and receiving neoadjuvant endocrine therapy did not decrease survival odds among female patients, authors report in the Journal of the American College of Surgeons.
A 3-year endeavor to scale up HIV prevention and education efforts among men who have sex with men in Dhaka, Bangladesh, showed only modest gains in the country where intercourse with a same-sex partner could mean a lifetime jail sentence.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Negotiations on a new coronavirus disease 2019 (COVID-19) relief package are reportedly on the brink of failure; as more than 100 COVID-19 vaccine candidates continue to be examined in clinical trials, some hints on pricing have emerged; the Trump administration removed its warnings on all international travel to Americans amid COVID-19.
In the primary analysis of a phase 3 study, ruxolitinib reduced spleen length and symptoms in patients with myelofibrosis, according to results published in British Journal of Haemotology.
This week, the top managed care news included CMS updates on telehealth and more; COVID-19 vaccine developments and remaining challenges; a study examines the impact of state policies on life expectancy.
Researchers found that patients with idiopathic pulmonary fibrosis (IPF) are at increased risk of developing several forms of cancer compared with the general population.
clonoSEQ, from Adaptive Biotechnologies, can detect 1 cancer cell among a million healthy cells.
A new analysis offers insights into how ozanimod works in patients with relapsing multiple sclerosis, as well as the impact of higher dosage.
Just like in clinical trials, a real-world analysis of patients with psoriatic arthritis who were treated with secukinumab achieved minimal disease activity, as well as other improvements.
Improving on the ability to confirm diagnosis of Parkinson disease (PD) earlier and determining who is at risk for PD were referenced as key factors in further slowing progression of the disease, according to review findings.
Prevention and early screening efforts need to be stepped up for patients with acute heart failure who contract pneumonia while hospitalized.
Results from a phase 2 trial of pembrolizumab as immune checkpoint inhibition against 5 types of solid tumors show that circulating tumor DNA (ctDNA) may be used to accurately predict response to treatment.
Health care workers of color are nearly 2 times more likely than their white colleagues to test positive for coronavirus disease 2019; Teladoc Health announced an agreement to acquire Livongo, a diabetes coaching company, for $18.5 billion; the CDC has issued a warning against ingesting alcohol-based hand sanitizer in response to reports of poisonings in the United States.
Robin Gelburd, JD, president of FAIR Health, discusses telehealth growth in May medical claims.
Bacterial changes in the oral cavity from immunosuppression, not HIV itself, are more likely to blame for the greater incidence of oral caries in children 6 months to 6 years, reports a study from the Department of Oral Biology at the Rutgers University School of Dental Medicine.
Researchers found that cough reflex sensitivity is amplified during chronic obstructive pulmonary disease (COPD) exacerbation and reduces after recovery, while its persistence can help serve as a predictor for future exacerbations.
The American College of Cardiology updates guidance on prescribing SGLT2 inhibitors and GLP-1 receptor agonists to patients with type 2 diabetes and cardiovascular disease or CV risk.
Hinge Health announced the expansion of its clinical and technical musculoskeletal (MSK) capabilities to cover the full continuum of MSK care. The move will provide the most complete back and joint health solution to employers and health plans.
A study based on real-world data collected from the West German Headache Center at the University Hospital Essen, Germany, concluded erenumab appears to be a promising treatment option for patients with highly therapy-refractory migraine.
Results from a large population-based cohort study, published in Arthritis Care & Research, found individuals with rheumatoid arthritis (RA) had a lower rate of incident type 2 diabetes (T2D) compared with the general non-RA population and cohorts with with hypertension, osteoarthritis (OA), and psoriatic arthritis (PsA).
